NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

Compare
57.48
+0.15
+(0.26%)
As of 1:39:32 PM EST. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 95.43B
Earnings 87M
Q4'23
Q1'24
Q2'24
Q3'24
0
20B
40B
60B
80B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

48.01 Low
65.58 Average
57.48 Current
93.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 21152425
Avg. Estimate 0.941.335.26.04
Low Estimate 0.451.014.685.43
High Estimate 1.291.735.827.49
Year Ago EPS 2.121.318.745.2

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 18102424
Avg. Estimate 96.9B92.96B371.65B386.44B
Low Estimate 94.15B91.05B367.97B370.54B
High Estimate 98.97B95.02B374.07B402.43B
Year Ago Sales 93.81B88.44B357.78B371.65B
Sales Growth (year/est) 3.29%5.12%3.88%3.98%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 1.991.71.731.46
EPS Actual 2.121.311.831.09
Difference 0.13-0.390.1-0.37
Surprise % 6.59%-22.79%5.95%-25.23%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.941.335.26.04
7 Days Ago 0.931.335.226.08
30 Days Ago 0.991.345.326.22
60 Days Ago 1.061.315.346.4
90 Days Ago 1.71.486.447.27

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --1----
Up Last 30 Days --1----
Down Last 7 Days 1--21
Down Last 30 Days 4275

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CVS -55.89%1.85%-40.47%16.19%
S&P 500 9.90%11.00%14.01%13.54%

Upgrades & Downgrades

Maintains Evercore ISI Group: Outperform to Outperform 1/27/2025
Maintains Truist Securities: Buy to Buy 1/6/2025
Upgrade Deutsche Bank: Hold to Buy 12/3/2024
Maintains TD Cowen: Buy to Buy 11/25/2024
Maintains Piper Sandler: Overweight to Overweight 11/25/2024
Reiterates Truist Securities: Buy to Buy 11/20/2024

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.